NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | -40.0% | 13,600 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 13,600 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 13,600 | +3.8% | 0.00% | – |
| Q3 2017 | $5,000 | -28.6% | 13,100 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | -12.5% | 13,100 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | 0.0% | 13,100 | 0.0% | 0.00% | – |
| Q4 2016 | $8,000 | -33.3% | 13,100 | 0.0% | 0.00% | – |
| Q3 2016 | $12,000 | +71.4% | 13,100 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -50.0% | 13,100 | -14.4% | 0.00% | – |
| Q1 2016 | $14,000 | -30.0% | 15,310 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -42.9% | 15,310 | 0.0% | 0.00% | – |
| Q3 2015 | $35,000 | +40.0% | 15,310 | 0.0% | 0.00% | – |
| Q2 2015 | $25,000 | -3.8% | 15,310 | -5.5% | 0.00% | – |
| Q1 2015 | $26,000 | +136.4% | 16,200 | +93.8% | 0.00% | – |
| Q3 2014 | $11,000 | 0.0% | 8,360 | +15.6% | 0.00% | – |
| Q2 2014 | $11,000 | -15.4% | 7,230 | +1.8% | 0.00% | – |
| Q1 2014 | $13,000 | -13.3% | 7,100 | 0.0% | 0.00% | – |
| Q4 2013 | $15,000 | -78.9% | 7,100 | -73.3% | 0.00% | – |
| Q3 2013 | $71,000 | -11.2% | 26,555 | -10.8% | 0.00% | – |
| Q2 2013 | $80,000 | – | 29,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|